Ascendis Pharma A/S (Ascendis Pharma A/S) Price-to-Tangible-Book : (As of Apr. 28, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma A/S Price-to-Tangible-Book?

As of today (2024-04-28), Ascendis Pharma A/S's share price is $135.90. Ascendis Pharma A/S's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-2.89. Hence, Ascendis Pharma A/S's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Ascendis Pharma A/S's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Ascendis Pharma A/S's highest Price to Tangible Book Ratio was 25.49. The lowest was 3.59. And the median was 8.06.

ASND's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.65
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Ascendis Pharma A/S's share price is $135.90. Ascendis Pharma A/S's Book Value per Sharefor the quarter that ended in Dec. 2023 was $-2.81. Hence, Ascendis Pharma A/S's P/B Ratio of today is .

Ascendis Pharma A/S Price-to-Tangible-Book Historical Data

The historical data trend for Ascendis Pharma A/S's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S Price-to-Tangible-Book Chart

Ascendis Pharma A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

10.12

8.85

7.72

25.49

Ascendis Pharma A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															25.49	34.64	76.87	-	-

Competitive Comparison of Ascendis Pharma A/S's Price-to-Tangible-Book

For the Biotechnology subindustry, Ascendis Pharma A/S's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Pharma A/S's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma A/S's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma A/S's Price-to-Tangible-Book falls into.

Ascendis Pharma A/S Price-to-Tangible-Book Calculation

Ascendis Pharma A/S's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	135.90	/	-2.892
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Ascendis Pharma A/S Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (NAS:ASND) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

http://www.ascendispharma.com

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.